These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31017794)

  • 1. Assessing Physical Stability Risk Using the Amorphous Classification System (ACS) Based on Simple Thermal Analysis.
    Zhou D; Schmitt EA; Law D; Brackemeyer PJ; Zhang GGZ
    Mol Pharm; 2019 Jun; 16(6):2742-2754. PubMed ID: 31017794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility.
    Zhou D; Zhang GG; Law D; Grant DJ; Schmitt EA
    J Pharm Sci; 2002 Aug; 91(8):1863-72. PubMed ID: 12115813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A calorimetric investigation of thermodynamic and molecular mobility contributions to the physical stability of two pharmaceutical glasses.
    Zhou D; Grant DJ; Zhang GG; Law D; Schmitt EA
    J Pharm Sci; 2007 Jan; 96(1):71-83. PubMed ID: 17031846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin.
    Zhou D; Zhang GG; Law D; Grant DJ; Schmitt EA
    Mol Pharm; 2008; 5(6):927-36. PubMed ID: 19434849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation into the crystallization tendency/kinetics of amorphous active pharmaceutical ingredients: A case study with dipyridamole and cinnarizine.
    Baghel S; Cathcart H; Redington W; O'Reilly NJ
    Eur J Pharm Biopharm; 2016 Jul; 104():59-71. PubMed ID: 27108783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanistic investigation of an amorphous pharmaceutical and its solid dispersions, part II: molecular mobility and activation thermodynamic parameters.
    Shmeis RA; Wang Z; Krill SL
    Pharm Res; 2004 Nov; 21(11):2031-9. PubMed ID: 15587925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insights into the crystallization of coamorphous drug systems.
    Heng W; Song Y; Luo M; Hu E; Wei Y; Gao Y; Pang Z; Zhang J; Qian S
    J Control Release; 2023 Feb; 354():489-502. PubMed ID: 36646287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical stability and solubility advantage from amorphous celecoxib: the role of thermodynamic quantities and molecular mobility.
    Gupta P; Chawla G; Bansal AK
    Mol Pharm; 2004; 1(6):406-13. PubMed ID: 16028352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Amorphous Drug Stability Predictions Using Easily Calculated, Predicted, and Measured Parameters.
    Nurzyńska K; Booth J; Roberts CJ; McCabe J; Dryden I; Fischer PM
    Mol Pharm; 2015 Sep; 12(9):3389-98. PubMed ID: 26236939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization kinetics and molecular mobility of an amorphous active pharmaceutical ingredient: A case study with Biclotymol.
    Schammé B; Couvrat N; Malpeli P; Delbreilh L; Dupray V; Dargent É; Coquerel G
    Int J Pharm; 2015 Jul; 490(1-2):248-57. PubMed ID: 26003417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying thermodynamic and kinetic parameters to predict the physical stability of two differently prepared amorphous forms of simvastatin.
    Graeser KA; Patterson JE; Rades T
    Curr Drug Deliv; 2009 Aug; 6(4):374-82. PubMed ID: 19534709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of advanced thermal analysis for characterization of crystalline and amorphous phases of carvedilol.
    Skotnicki M; Czerniecka-Kubicka A; Neilsen G; Woodfield BF; Pyda M
    J Pharm Biomed Anal; 2022 Aug; 217():114822. PubMed ID: 35550491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.
    Baghel S; Cathcart H; O'Reilly NJ
    J Pharm Sci; 2016 Sep; 105(9):2527-2544. PubMed ID: 26886314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly supersaturated solutions of amorphous drugs approaching predictions from configurational thermodynamic properties.
    Matteucci ME; Miller MA; Williams RO; Johnston KP
    J Phys Chem B; 2008 Dec; 112(51):16675-81. PubMed ID: 19367943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependence of molecular mobility during structural relaxation and its impact on organic amorphous solids: an investigation based on a calorimetric approach.
    Mao C; Chamarthy SP; Pinal R
    Pharm Res; 2006 Aug; 23(8):1906-17. PubMed ID: 16858653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.
    Aso Y; Yoshioka S; Kojima S
    J Pharm Sci; 2004 Feb; 93(2):384-91. PubMed ID: 14705195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
    Dukeck R; Sieger P; Karmwar P
    Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fast and reliable empirical approach for estimating solubility of crystalline drugs in polymers for hot melt extrusion formulations.
    Kyeremateng SO; Pudlas M; Woehrle GH
    J Pharm Sci; 2014 Sep; 103(9):2847-2858. PubMed ID: 24634063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
    McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
    Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Development of Quasi-isothermal Calorimetry for the Measurement of Drug-Polymer Miscibility and Crystallization Kinetics: Olanzapine-Loaded PLGA Microparticles.
    Askin S; Zhao M; Gonçalves AD; Gaisford S; Craig DQM
    Mol Pharm; 2018 Aug; 15(8):3332-3342. PubMed ID: 29933697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.